Insiders · Profile

Harris Erik

EVP & Chief Commercial Officer at Ultragenyx Pharmaceutical. Filing since 3 Jun 2020. CIK 0001780113

Company
Date
Role
Action
Shares
Amount
Of holding
2 Mar 2026
EVP & Chief Commercial Officer
Sold at will
10,539
$240.29K
10.5%
3 Mar 2025
EVP & Chief Commercial Officer
Sold at will
15,103
$635.84K
14.7%
1 Mar 2024
EVP & Chief Commercial Officer
Sold at will
4,768
$256.33K
6.6%
5 Sep 2023
EVP & Chief Commercial Officer
Sold at will
6,000
$227.76K
10.5%
19 Jun 2023
EVP & Chief Commercial Officer
Sold at will
305
$14.70K
0.5%
1 Mar 2023
EVP & Chief Commercial Officer
Sold, plan not stated
3,664
$165.80K
6.0%
19 Jun 2022
EVP & Chief Commercial Officer
Sold, plan not stated
295
$16.16K
0.8%
1 Mar 2022
EVP & Chief Commercial Officer
Sold, plan not stated
2,713
$180.74K
10.8%
14 Oct 2021
EVP & Chief Commercial Officer
Sold, plan not stated
303
$24.59K
1.2%
6 Jul 2021
EVP & Chief Commercial Officer
Sold, plan not stated
375
$34.32K
1.5%
21 Jun 2021
EVP & Chief Commercial Officer
Sold, plan not stated
572
$54.32K
2.2%
19 Jun 2021
EVP & Chief Commercial Officer
Sold, plan not stated
437
$41.35K
1.6%
7 May 2021
EVP & Chief Commercial Officer
Sold, plan not stated
393
$44.67K
1.4%
6 May 2021
EVP & Chief Commercial Officer
Sold, plan not stated
307
$34.90K
1.1%
20 Apr 2021
EVP & Chief Commercial Officer
Sold, plan not stated
396
$41.29K
1.4%
2 Mar 2021
EVP & Chief Commercial Officer
Sold, plan not stated
707
$97.68K
2.5%
1 Mar 2021
EVP & Chief Commercial Officer
Sold, plan not stated
2,470
$341.28K
8.0%
14 Oct 2020
EVP & Chief Commercial Officer
Sold, plan not stated
220
$19.36K
0.9%
3 Jun 2020
EVP & Chief Commercial Officer
Sold, plan not stated
2,516
$187.92K
10.8%
19 decisions on file.